Tenofovir clinical trials
Also written Viread, TDF and GSK548470.
Counted the way a researcher would: Tenofovir with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Tenofovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Tenofovir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Oct 2001 · VIREAD · NDA 021356 (FDA, Drugs@FDA)
- European Union
- 4 Feb 2002 · Viread · EMEA/H/C/000419 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
274 studies that test it; most in 2012 (29)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 9 |
| 2005 | 9 |
| 2006 | 10 |
| 2007 | 9 |
| 2008 | 18 |
| 2009 | 14 |
| 2010 | 8 |
| 2011 | 18 |
| 2012 | 29 |
| 2013 | 8 |
| 2014 | 11 |
| 2015 | 25 |
| 2016 | 10 |
| 2017 | 14 |
| 2018 | 17 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 74 · Other 217
Gilead Sciences (28) · National Institute of Allergy and Infectious Diseases (NIAID) (18) · CONRAD (9) · ANRS, Emerging Infectious Diseases (8) · GlaxoSmithKline (8) · Bristol-Myers Squibb (8) · University of North Carolina, Chapel Hill (6) · Kirby Institute (6)
Often tested with
Tested in the same studies.
Emtricitabine (81) · Lamivudine (36) · Efavirenz (21) · Ritonavir (20) · Entecavir (16) · Atazanavir (12) · Raltegravir (11) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (9)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Tenofovir is the comparator. A study of two new drugs counts under both.
- 1Dolutegravir · Johns Hopkins University · next primary completion Jan 2028
- 1Dolutegravir Sodium/Lamivudine · Johns Hopkins University · next primary completion Jan 2028
Reaching primary completion within a year · 5
Studies that test Tenofovir.
- Nov 2026Antiviral Clinical Trial for Long Covid-19Phase 2 · Icahn School of Medicine at Mount Sinai
- May 2027Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV InfectionPhase 4 · University of California, San Francisco
- Aug 2027Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant WomenPhase 4 · ANRS, Emerging Infectious Diseases
- Aug 2027Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIVPhase 4 · University of Witwatersrand, South Africa
- Sep 2027Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesPhase 2 · ANRS, Emerging Infectious Diseases
Studies
Open first, then newest update. How each study uses Tenofovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 291
- Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized StudyRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT05652478Written as Tenofovir Disoproxil Fumarate
- Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)RecruitingPhase 2Merck Sharp & Dohme LLCNCT04375800Written as DOR/3TC/TDF
- Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIVNot yet recruitingPhase 4University of Witwatersrand, South AfricaNCT07673965Written as Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Doravirine 100mg
- Efficacy and Safety of Doravirine in the Rapid InitiationRecruitingPhase 4Fundación HuéspedNCT07357584Written as Doravirine / lamivudine/ Tenofovir Disoproxil Oral Tablet
- Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's DiseaseNot yet recruitingPhase 1Brigham and Women's HospitalNCT07795307Written as Emtricitabine and tenofovir disoproxil fumarate combination
- DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruitingPhase 3ANRS, Emerging Infectious DiseasesNCT06203132Written as Doravirine + tenofovir DF + lamivudine
- Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir RegimensNot yet recruitingPhase 4Shanghai Public Health Clinical CenterNCT07631897Written as Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
- Antiviral Clinical Trial for Long Covid-19RecruitingPhase 2Icahn School of Medicine at Mount SinaiNCT06511063Written as tenofovir disoproxil/emtricitabine
- DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or ObesityRecruitingPhase 3José Antonio Mata MarínNCT07075146Written as DOR/3TC/TDF
- Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's DiseaseRecruitingPhase 1The Fourth Affiliated Hospital of Zhejiang University School of MedicineNCT06356662Written as Tenofovir Disoproxil Fumarate
- Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesNot yet recruitingPhase 2ANRS, Emerging Infectious DiseasesNCT06338826Written as TDF - 245mg or TAF -25mg associated to 3TC - 300mg or FTC - 200mg and a NNRTI or PI/r or INSTI
- Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTIRecruitingPhase 4Instituto Mexicano del Seguro SocialNCT06602622Written as Doravirine + tenofovir DF + lamivudine
- HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.RecruitingPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT04640129Written as PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
- Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan AfricaNot yet recruitingPhase 3MRC/UVRI and LSHTM Uganda Research UnitNCT06133686Written as Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- The COMBAT HBV Feasibility TrialCompletedPhase 4University of North Carolina, Chapel HillNCT05705427Written as Tenofovir Disoproxil Fumarate 300 MG
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant WomenActive, not recruitingPhase 4ANRS, Emerging Infectious DiseasesNCT05403047Written as Fumarate, Tenofovir Disoproxil
- PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)Active, not recruitingEarly Phase 1Oak Crest Institute of ScienceNCT03255915Written as Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC)
- Reducing Vertical Transmission of Hepatitis B in AfricaActive, not recruitingPhase 3University of Alabama at BirminghamNCT04704024Written as Tenofovir Disoproxil Fumarate
- IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration ProjectCompletedPhase 4Rutgers, The State University of New JerseyNCT03058835Written as tenofovir disoproxil and emtricitabine
- Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV InfectionActive, not recruitingPhase 4University of California, San FranciscoNCT02656511Written as Emtricitabine/Tenofovir
See all 291 studies that test Tenofovir →
Given beside what is tested · 95 — Tenofovir is usual care or a partner of the new treatment
- Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseNot yet recruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07797231Written as Tenofovir Disoproxil Fumarate Tablets
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (A)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT07852091Written as ETV/TDF/TAF
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT05769816Written as NAs
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT05771402Written as NAs
- Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCTRecruitingPhase 3Africa Health Research InstituteNCT06250504Written as tenofovir disoproxil and emtricitabine
- Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical ResectionNot yet recruitingEarly Phase 1Ningbo No.2 HospitalNCT07553767Written as TDF
- Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB PatientsRecruitingNot applicableBeijing 302 HospitalNCT06457477Written as NAs
- A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusCompletedPhase 2Janssen Research & Development, LLCNCT04535544Written as Tenofovir disoproxil
- Inhibition of HBV Replication and Biological Reversal of Cirrhosis (F3-F4) and HCC by FlavonoidsCompletedPhase 4Trieu, Nguyen Thi, M.D.NCT07084948Written as Tenofovir
- Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)CompletedPhase 3French National Agency for Research on AIDS and Viral HepatitisNCT00302822Written as emtricitabine/tenofovir
- Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With MenCompletedPhase 2/3National Institute of Allergy and Infectious Diseases (NIAID)NCT02720094Written as TDF/FTC tablets
- A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B InfectionCompletedPhase 1/2Vir Biotechnology, Inc.NCT05612581Written as TDF
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedPhase 2Arrowhead PharmaceuticalsNCT02577029Written as tenofovir disoproxil
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604212Written as tenofovir
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02738008Written as tenofovir
- A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) InfectionTerminatedPhase 2Arrowhead PharmaceuticalsNCT02604199Written as tenofovir
- A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)TerminatedPhase 1Arrowhead PharmaceuticalsNCT02797522Written as tenofovir
- Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B VirusTerminatedPhase 2Arrowhead PharmaceuticalsNCT02452528Written as Tenofovir
- Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected WomenActive, not recruitingPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT03164564Written as Oral TDF/FTC
- Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant PatientsCompletedPhase 4Fundacion Clinic per a la Recerca BiomédicaNCT03360682Written as Tenofovir Disoproxil 245Mg Tablet
Showing 20 of 95.
As the comparator · 63 — what is tested is compared with Tenofovir
- Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentRecruitingPhase 3Johns Hopkins UniversityNCT06497465Written as Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)
- TAF in Early/Middle Pregnancy With CHBEnrolling by invitationPhase 4The Third Affiliated Hospital of Guangzhou Medical UniversityNCT07668934Written as TDF
- Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral LoadsRecruitingNot applicableGuangzhou 8th People's HospitalNCT06947356Written as TDF group
- Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLFRecruitingNot applicableThird Affiliated Hospital, Sun Yat-Sen UniversityNCT03920618Written as Tenofovir Disoproxil Fumarate
- A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)Active, not recruitingPhase 2Aligos TherapeuticsNCT06963710Written as TDF
- Biktarvy in Treatment-Naïve Late Presenters With HIV-1 InfectionCompletedPhase 4Peking Union Medical College HospitalNCT04296695Written as TDF/3TC/EFV
- The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB PatientsActive, not recruitingNot applicableBeijing 302 HospitalNCT06357806Written as NAs
- Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3CompletedPhase 4Fundación HuéspedNCT04880395Written as Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
- Safety & Efficacy of Dual Therapy With Raltegravir/LamivudineCompletedPhase 3Juan A. ArnaizNCT02284035Written as EFV/TDF/FTC
- The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)CompletedPhase 2HIV Prevention Trials NetworkNCT01327651Written as Daily dosing
- Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDFCompletedPhase 4Humanity and Health Research CentreNCT03356834Written as Tenofovir disoproxil fumarate(TDF)
- Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)CompletedPhase 3Gilead SciencesNCT02836249Written as TDF
- Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)CompletedPhase 3Gilead SciencesNCT02836236Written as TDF
- PK of TAF and TDF for PrEP in Pregnant and Postpartum WomenCompletedPhase 3University of California, Los AngelesNCT04937881Written as Tenofovir Disoproxil Fumarate
- A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BCompletedPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT04846491Written as TDF
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedPhase 3ViiV HealthcareNCT01910402Written as Tenofovir/emtricitabine FDC
- Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCCCompletedPhase 3Guangxi Medical UniversityNCT02650271Written as Tenofovir
- Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TCTerminatedPhase 3Bristol-Myers SquibbNCT01620944Written as Tenofovir/Emtricitabine
- An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedPhase 3ViiV HealthcareNCT02831764Written as Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
- Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e AntigenCompletedPhase 3Gilead SciencesNCT01940471Written as TDF
Showing 20 of 63.
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted1
- The COMBAT HBV Feasibility TrialNov 16, 2026NCT05705427
Codes
What other systems call Tenofovir · ClinicalTrials.gg INT006531
- MeSH (NLM) D000068698TenofovirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 99YXE507ILTENOFOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 117466One source FDA
- Wikidata Q106010187tenofovir hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29490TenofovirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068698 | Tenofovir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 99YXE507IL | TENOFOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 117466 | — | One source FDA |
| Wikidata | Q106010187 | tenofovir hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29490 | Tenofovir | One source FDA |
Also registered as tenofovir disoproxil (UNII F4YU4LON7I · RxNorm 300195) and tenofovir disoproxil fumarate (UNII OTT9J7900I · RxNorm 322248).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.